Visit CONTRACT PHARMA at Booth 1163

Catalent Completes $4.6M Singapore Expansion


Clinical Supply Facility provides additional GMP space for secondary packaging

Catalent Pharma Solutions has completed a two-year, $4.6 million expansion at its Singapore clinical supply facility, which serves as a strategic hub in Catalent’s Asia-Pacific network and global clinical supply business. The expansion provides additional GMP space for secondary packaging, and has doubled ambient storage, and quadrupled cold storage capacity at the site.
The site opened in 1998 and has seen significant growth, almost tripling in size to almost 20,000-sq.-ft., and headcount since 2012. 
“We are particularly pleased to have completed the expansion in a year that marks the 20th anniversary of what was Catalent’s first facility in the Asia-Pacific region,” said Bernie Clark, vice president marketing, Catalent Clinical Supply Services. “Supported by many long-serving employees, the Singapore site has undergone tremendous growth over the past two decades and now routinely distributes to 18 countries in the region.”
Catalent’s clinical supply services business has facilities in the U.S., U.K., Germany, Japan and China, and an extended network of over 50 audited depots.